Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TDOC Stock Forecast 2025-2026
$7.52
Current Price
$1.27B
Market Cap
Buy 5
Hold 19
Sell 0
Wall St Analyst Ratings
Distance to TDOC Price Targets
+59.6%
To High Target of $12.00
+6.4%
To Median Target of $8.00
-6.9%
To Low Target of $7.00
TDOC Price Momentum
+5.8%
1 Week Change
+10.1%
1 Month Change
-40.9%
1 Year Change
-17.3%
Year-to-Date Change
-50.6%
From 52W High of $15.21
+18.4%
From 52W Low of $6.35
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Teladoc (TDOC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on TDOC and similar high-potential opportunities.
Latest TDOC Stock Price Targets & Analyst Predictions
Based on our analysis of 46 Wall Street analysts, TDOC has a neutral consensus with a median price target of $8.00 (ranging from $7.00 to $12.00). The overall analyst rating is Buy (6.7/10). Currently trading at $7.52, the median forecast implies a 6.4% upside. This outlook is supported by 5 Buy, 19 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Richard Close at Canaccord Genuity, projecting a 59.6% upside. Conversely, the most conservative target is provided by Elizabeth Anderson at Evercore ISI Group, suggesting a 6.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TDOC Analyst Ratings
5
Buy
19
Hold
0
Sell
TDOC Price Target Range
Low
$7.00
Average
$8.00
High
$12.00
Current: $7.52
Latest TDOC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TDOC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 8, 2025 | Wells Fargo | Stan Berenshteyn | Equal-Weight | Maintains | $8.00 |
| May 1, 2025 | Evercore ISI Group | Elizabeth Anderson | In-Line | Maintains | $7.00 |
| May 1, 2025 | Stifel | David Grossman | Hold | Maintains | $8.00 |
| May 1, 2025 | Canaccord Genuity | Richard Close | Buy | Maintains | $12.00 |
| May 1, 2025 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| May 1, 2025 | Goldman Sachs | David Roman | Buy | Maintains | $10.00 |
| Apr 25, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $8.75 |
| Apr 21, 2025 | Jefferies | Glen Santangelo | Hold | Maintains | $8.00 |
| Apr 11, 2025 | B of A Securities | Allen Lutz | Neutral | Maintains | $8.00 |
| Mar 3, 2025 | Goldman Sachs | David Roman | Buy | Maintains | $13.00 |
| Feb 27, 2025 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $12.00 |
| Feb 27, 2025 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| Feb 18, 2025 | Goldman Sachs | David Roman | Buy | Maintains | $16.00 |
| Feb 12, 2025 | B of A Securities | Allen Lutz | Neutral | Maintains | $13.50 |
| Feb 6, 2025 | B of A Securities | Allen Lutz | Neutral | Maintains | $11.50 |
| Jan 24, 2025 | RBC Capital | Sean Dodge | Outperform | Maintains | $12.00 |
| Jan 24, 2025 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $12.00 |
| Dec 4, 2024 | Piper Sandler | Jessica Tassan | Overweight | Reiterates | $13.00 |
| Nov 15, 2024 | Goldman Sachs | David Roman | Buy | Initiates | $14.00 |
| Nov 1, 2024 | Deutsche Bank | George Hill | Hold | Maintains | $12.00 |
Teladoc Health Inc. (TDOC) Competitors
The following stocks are similar to Teladoc based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Teladoc Health Inc. (TDOC) Financial Data
Teladoc Health Inc. has a market capitalization of $1.27B with a P/E ratio of -1.3x. The company generates $2.55B in trailing twelve-month revenue with a -39.7% profit margin.
Revenue growth is -2.6% quarter-over-quarter, while maintaining an operating margin of -8.7% and return on equity of -54.5%.
Valuation Metrics
Market Cap
$1.27B
Enterprise Value
$1.67B
P/E Ratio
-1.3x
PEG Ratio
-8.1x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
-2.6%
Gross Margin
+68.7%
Operating Margin
-8.7%
Net Margin
-39.7%
EPS Growth
-2.6%
Financial Health
Cash/Price Ratio
+90.5%
Current Ratio
1.7x
Debt/Equity
111.2x
ROE
-54.5%
ROA
-3.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Teladoc Health Inc. (TDOC) Business Model
About Teladoc Health Inc.
What They Do
Provides telemedicine and virtual healthcare services.
Business Model
Teladoc Health Inc. generates revenue by offering a platform that connects patients with healthcare professionals for remote consultations, including video calls and phone interactions. The company earns money through subscription fees from health plans, employers, and direct-to-consumer services, capitalizing on the increasing demand for accessible digital healthcare solutions.
Additional Information
Headquartered in Purchase, New York, Teladoc is a leader in the telemedicine industry, focused on enhancing healthcare accessibility while reducing costs. Its services cover general health, mental health, and chronic condition management, positioning it strategically to meet the growing trend towards virtual healthcare.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
4,620
CEO
Mr. Charles Divita III, CPA
Country
United States
IPO Year
2015
Website
www.teladochealth.comTeladoc Health Inc. (TDOC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance.
May 16, 2025
By Debanjana Dey
Analyst Blog
Latest News
Quick Summary
Equity markets present bargains with underperforming stocks that may recover, while investors should avoid companies unlikely to rebound soon.
Why It Matters
Identifying undervalued stocks could present buying opportunities, while avoiding poorly performing companies may protect against further losses. Market dynamics suggest potential for recovery.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Teladoc Health projects Integrated Care membership will reach 101 million to 103 million by 2025.
Why It Matters
Teladoc's projected growth in Integrated Care members indicates increasing demand for telehealth services, suggesting potential revenue growth and market expansion, which can positively impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Teladoc Health, Inc. (NYSE:TDOC) issued inducement awards to five new employees, signaling potential growth and investment in talent.
Why It Matters
Inducement awards signal Teladoc's growth and talent acquisition strategy, potentially enhancing its competitive position in virtual care, which could influence stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Teladoc Health: No Real Rescue In Sight
15 days ago
Quick Summary
Teladoc Health seeks a turnaround amid stagnant growth, focusing heavily on virtual mental health. It trades at 5x EV/EBITDA with a $1.2B market cap, but lacks sustainable growth prospects.
Why It Matters
Teladoc's stagnant growth and reliance on virtual mental health raise concerns about its future, despite low valuation. A lack of innovation could hinder long-term investment appeal.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Teladoc Health has acquired UpLift, a virtual mental health service provider, for $30 million in cash, enhancing its offerings in therapy and medication management.
Why It Matters
Teladoc's acquisition of UpLift enhances its mental health service offerings, potentially increasing revenue streams and market share in a growing telehealth sector.
Source: CNBC
Market Sentiment:
Neutral
Quick Summary
Teladoc Health's stock is at a record low, trading at $7.16, down 21% this year and 46% over the past 12 months, ahead of its first-quarter earnings report.
Why It Matters
Teladoc Health's declining stock signals deepening investor concerns, potentially affecting market sentiment and future growth prospects amid upcoming earnings results.
Source: Invezz
Market Sentiment:
Negative
Frequently Asked Questions About TDOC Stock
What is Teladoc Health Inc.'s (TDOC) stock forecast for 2025?
Based on our analysis of 46 Wall Street analysts, Teladoc Health Inc. (TDOC) has a median price target of $8.00. The highest price target is $12.00 and the lowest is $7.00.
Is TDOC stock a good investment in 2025?
According to current analyst ratings, TDOC has 5 Buy ratings, 19 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.52. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TDOC stock?
Wall Street analysts predict TDOC stock could reach $8.00 in the next 12 months. This represents a 6.4% increase from the current price of $7.52. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Teladoc Health Inc.'s business model?
Teladoc Health Inc. generates revenue by offering a platform that connects patients with healthcare professionals for remote consultations, including video calls and phone interactions. The company earns money through subscription fees from health plans, employers, and direct-to-consumer services, capitalizing on the increasing demand for accessible digital healthcare solutions.
What is the highest forecasted price for TDOC Teladoc Health Inc.?
The highest price target for TDOC is $12.00 from Richard Close at Canaccord Genuity, which represents a 59.6% increase from the current price of $7.52.
What is the lowest forecasted price for TDOC Teladoc Health Inc.?
The lowest price target for TDOC is $7.00 from Elizabeth Anderson at Evercore ISI Group, which represents a -6.9% decrease from the current price of $7.52.
What is the overall TDOC consensus from analysts for Teladoc Health Inc.?
The overall analyst consensus for TDOC is neutral. Out of 46 Wall Street analysts, 5 rate it as Buy, 19 as Hold, and 0 as Sell, with a median price target of $8.00.
How accurate are TDOC stock price projections?
Stock price projections, including those for Teladoc Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 7:36 PM UTC